Financhill
Back

Alaunos Therapeutics Vs. Expedia Group Industry Stock Comparison

Sell
21

TCRT
Alaunos Therapeutics

Last Price:
1.17
Seasonality Move:
9.34%
Sell
48

EXPE
Expedia Group

Last Price:
113.98
Seasonality Move:
8.66%
Sell
21
Alaunos Therapeutics (TCRT) is a Sell

Is Alaunos Therapeutics a Buy, Sell or Hold?

  • The current Alaunos Therapeutics [TCRT] share price is $1.16. The Score for TCRT is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • TCRT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Expedia Group (EXPE) is a Sell

Is Expedia Group a Buy, Sell or Hold?

  • The current Expedia Group [EXPE] share price is $114.01. The Score for EXPE is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • EXPE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TCRT Stock Price Chart

What is Alaunos Therapeutics's stock price today?

  • The Alaunos Therapeutics share price today is $1.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TCRT is experiencing slight selling pressure.

EXPE Stock Price Chart

What is Expedia Group's stock price today?

  • The Expedia Group share price today is $114.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EXPE is experiencing slight buying pressure.

TCRT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 37.16 Sell
Chaikin Money Flow: -13832 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.18 - 1.34) Sell
Bollinger Bands (100): (1.3 - 2.18) Sell

EXPE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.51 Sell
Relative Strength Index (14 RSI): 32.68 Sell
Chaikin Money Flow: 1004127 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (114.28 - 134.18) Sell
Bollinger Bands (100): (125.67 - 148.45) Sell

TCRT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.25 Sell
20-day SMA: 1.26 Sell
50-day SMA: 1.51 Sell
200-day SMA: 1.81 Sell
8-day EMA: 1.24 Sell
20-day EMA: 1.3 Sell
50-day EMA: 1.46 Sell
200-day EMA: 2.86 Sell

EXPE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.87 Buy
20-day SMA: 123.1 Sell
50-day SMA: 129.38 Sell
200-day SMA: 125.89 Sell
8-day EMA: 114.63 Sell
20-day EMA: 120.08 Sell
50-day EMA: 127.21 Sell
200-day EMA: 126.93 Sell

Alaunos Therapeutics Earnings Growth & TCRT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.65 per share, and a decrease next year of $1.35 per share.

Expedia Group Earnings Growth & EXPE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.46 per share, a decrease next quarter of $2.62 per share, an increase this year of $2.12 per share, and an increase next year of $2.83 per share.

Alaunos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Expedia Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):